乳腺癌不同细胞系特点.pdfVIP

Luminal A ER+, PR+/–, HER2–Ki67 low, endocrine responsive, often chemotherapy responsive MCF-7, T47D, SUM185 Luminal B ER+, PR+/–, HER2+ Ki67 high, usually endocrine responsive, variable to chemotherapy. HER2+ are BT474, ZR-75 trastusumab responsive Basal E –, P –, HER2– EGFR+ an